These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12611853)

  • 1. Comparative effectiveness of antipsychotic drugs.
    Osser DN; Akhter A
    Am J Psychiatry; 2003 Mar; 160(3):590; author reply 592-3. PubMed ID: 12611853
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effectiveness of antipsychotic drugs.
    Messori A
    Am J Psychiatry; 2003 Mar; 160(3):591-2; author reply 592-3. PubMed ID: 12611854
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effectiveness of antipsychotic drugs.
    Meibach RC
    Am J Psychiatry; 2003 Mar; 160(3):589-90; author reply 592-3. PubMed ID: 12611851
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative effectiveness of antipsychotic drugs.
    Gupta S
    Am J Psychiatry; 2003 Mar; 160(3):591; author reply 592-3. PubMed ID: 12611855
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative effectiveness of antipsychotic drugs.
    Adityanjee
    Am J Psychiatry; 2003 Mar; 160(3):590-1; author reply 592-3. PubMed ID: 12611852
    [No Abstract]   [Full Text] [Related]  

  • 6. Improvement of cognitive dysfunction after treatment with second-generation antipsychotics.
    Weiss E; Kemmler G; Fleischhacker WW
    Arch Gen Psychiatry; 2002 Jun; 59(6):572-3; author reply 573-5. PubMed ID: 12044210
    [No Abstract]   [Full Text] [Related]  

  • 7. An importance of dose in antipsychotic combination therapy for schizophrenia.
    Suzuki T
    J Clin Psychopharmacol; 2011 Jun; 31(3):399; author reply 399-400. PubMed ID: 21532376
    [No Abstract]   [Full Text] [Related]  

  • 8. Choice of and decreasing of the dosage of risperidone in the treatment of schizophrenia. Global versus individual criteria.
    Gómez-Perretta C
    Actas Esp Psiquiatr; 2007; 35(1):77-8. PubMed ID: 17323229
    [No Abstract]   [Full Text] [Related]  

  • 9. Olanzapine and haloperidol for residual symptoms.
    de Haan L; van Beveren N
    Am J Psychiatry; 2005 Jul; 162(7):1392-3; author reply 1393. PubMed ID: 15994737
    [No Abstract]   [Full Text] [Related]  

  • 10. Recommended haloperidol and risperidone doses in first-episode psychosis.
    McGorry PD
    J Clin Psychiatry; 1999 Nov; 60(11):794-5. PubMed ID: 10584773
    [No Abstract]   [Full Text] [Related]  

  • 11. Amisulpride: a review of its efficacy in schizophrenia.
    Möller HJ
    Acta Psychiatr Scand Suppl; 2000; 400():17-22. PubMed ID: 10823307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-benefits of risperidone.
    Bilsker D
    Psychiatr Serv; 1996 Mar; 47(3):309-10. PubMed ID: 8820560
    [No Abstract]   [Full Text] [Related]  

  • 13. Risperidone and clozapine for treatment-resistant schizophrenia.
    Meltzer HY
    Am J Psychiatry; 1999 Jul; 156(7):1126-7; author reply 1127-8. PubMed ID: 10401484
    [No Abstract]   [Full Text] [Related]  

  • 14. Clozapine versus risperidone in treatment-refractory schizophrenia: possible impact of dosing strategies.
    Lane HY; Chang WH
    J Clin Psychiatry; 1999 Jul; 60(7):487-8. PubMed ID: 10453806
    [No Abstract]   [Full Text] [Related]  

  • 15. Initial dosing strategies for long-acting injectable risperidone.
    Viner MW; Matuszak JM; Knight LJ
    J Clin Psychiatry; 2006 Aug; 67(8):1310-1. PubMed ID: 16965217
    [No Abstract]   [Full Text] [Related]  

  • 16. Dose selection and comparator drugs in schizophrenia research.
    Kane JM
    J Clin Psychiatry; 2001; 62 Suppl 9():29-32; discussion 33-4. PubMed ID: 11379828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of antipsychotic dose reduction.
    Uchida H; Suzuki T; Takeuchi H; Mamo DC
    Am J Psychiatry; 2010 Aug; 167(8):994; author reply 994-5. PubMed ID: 20693469
    [No Abstract]   [Full Text] [Related]  

  • 19. Methodological issues in a study of long-term maintenance therapy with quetiapine versus haloperidol decanoate.
    Adetunji B; Basil B; Mathews M; Williams A; Osinowo T
    J Clin Psychiatry; 2006 Mar; 67(3):497; author reply 497-8. PubMed ID: 16649843
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of long-acting risperidone.
    Pinninti NR; Mago R
    Psychiatr Serv; 2005 Jan; 56(1):105; author reply 106-7. PubMed ID: 15637204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.